HemaSphere (Apr 2022)

P25: CARFILZOMIB-BASED TREATMENTS COULD BE ADDED TO IMPEDE-VTE SCORE TO BETTER PREDICT VENOUS THROMBOEMBOLIC RISK IN MM PATIENTS

  • S Morè,
  • V M Manieri,
  • L Corvatta,
  • E Morsia,
  • S Rupoli,
  • A Olivieri,
  • M Offidani

DOI
https://doi.org/10.1097/01.HS9.0000829672.61767.68
Journal volume & issue
Vol. 6
pp. 25 – 25

Abstract

Read online

No abstracts available.